[go: up one dir, main page]

EE200800065A - Prasoloprimidinoonhendit sisaldav toimeaine eesn„„rmesuurenemuse „rahoidmiseks ja raviks - Google Patents

Prasoloprimidinoonhendit sisaldav toimeaine eesn„„rmesuurenemuse „rahoidmiseks ja raviks

Info

Publication number
EE200800065A
EE200800065A EEP200800065A EEP200800065A EE200800065A EE 200800065 A EE200800065 A EE 200800065A EE P200800065 A EEP200800065 A EE P200800065A EE P200800065 A EEP200800065 A EE P200800065A EE 200800065 A EE200800065 A EE 200800065A
Authority
EE
Estonia
Prior art keywords
rimidinone
rasolop
enlargement
maintenance
compound
Prior art date
Application number
EEP200800065A
Other languages
English (en)
Inventor
Young Yu Jae
Min Choi Seul
Koo Kang Kyung
Ok Ahn Byoung
Yoo Moohi
Original Assignee
Dong-A Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong-A Pharmaceutical Co., Ltd. filed Critical Dong-A Pharmaceutical Co., Ltd.
Publication of EE200800065A publication Critical patent/EE200800065A/et
Publication of EE05532B1 publication Critical patent/EE05532B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200800065A 2006-04-04 2006-04-04 Pürasolopürimidinoonühendit sisaldav farmatseutiline kompositsioon eesnäärme- suurenemuse ärahoidmiseks ja raviks EE05532B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2006/001242 WO2007114534A1 (en) 2006-04-04 2006-04-04 Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound

Publications (2)

Publication Number Publication Date
EE200800065A true EE200800065A (et) 2008-12-15
EE05532B1 EE05532B1 (et) 2012-04-16

Family

ID=38563793

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200800065A EE05532B1 (et) 2006-04-04 2006-04-04 Pürasolopürimidinoonühendit sisaldav farmatseutiline kompositsioon eesnäärme- suurenemuse ärahoidmiseks ja raviks

Country Status (10)

Country Link
US (1) US8148386B2 (et)
JP (1) JP4975805B2 (et)
AU (1) AU2006341342B2 (et)
BR (1) BRPI0621588A2 (et)
CA (1) CA2647932C (et)
EE (1) EE05532B1 (et)
IL (1) IL194463A (et)
MX (1) MX2008012549A (et)
NZ (1) NZ571673A (et)
WO (1) WO2007114534A1 (et)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080194529A1 (en) * 2007-02-12 2008-08-14 Auspex Pharmaceuticals, Inc. HIGHLY SELECTIVE and LONG-ACTING PDE5 MODULATORS
WO2012007849A2 (en) * 2010-07-15 2012-01-19 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating genitourinary system disorders
US9308275B2 (en) * 2010-07-15 2016-04-12 Oleg Iliich Epshtein Method of increasing the effect of an activated-potentiated form of an antibody
RU2758373C2 (ru) * 2017-05-22 2021-10-28 Топадур Фарма Аг Новые активаторы растворимой гуанилатциклазы и ингибиторы фосфодиэстеразы с двойным механизмом действия и их применение

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9823102D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
KR100353014B1 (ko) * 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
CA2475377A1 (en) * 2002-02-07 2003-08-14 Pfizer Inc. Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome

Also Published As

Publication number Publication date
US20090099357A1 (en) 2009-04-16
JP2009532463A (ja) 2009-09-10
AU2006341342B2 (en) 2010-05-20
CA2647932A1 (en) 2007-10-11
AU2006341342A1 (en) 2007-10-11
CA2647932C (en) 2011-06-07
IL194463A (en) 2014-11-30
BRPI0621588A2 (pt) 2011-12-13
US8148386B2 (en) 2012-04-03
IL194463A0 (en) 2009-08-03
NZ571673A (en) 2011-08-26
MX2008012549A (es) 2009-01-14
WO2007114534A1 (en) 2007-10-11
EE05532B1 (et) 2012-04-16
JP4975805B2 (ja) 2012-07-11

Similar Documents

Publication Publication Date Title
EP2131848A4 (en) COMPOSITIONS AND METHODS FOR REINFORCED ACTIVITY OF BIOLOGICAL ACTIVE MOLECULES
BRPI0822625A2 (pt) "dispositivo espaçador modular para o tratamento de infecções por próteses"
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
SMAP200900055A (it) Chinazoline per l'inibizione di pdk1
SMAP200800059A (it) Chinazoline per l'inibizione di pdk1
JP2008539179A5 (ja) 殺虫活性物質併用の組み合わせ
BRPI0910495A2 (pt) "formulação, método de tratamento de plantas, método de aumento da eficácia de uma formulação, herbicida, e, uso de uma mistura"
CR10245A (es) "nuevas combinaciones terapéuticas para el tratamiento de la depresión"
BRPI0820568A2 (pt) Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal
SI2024368T1 (sl) Derivati 6,7,8,9-tetrahidro-5h-pirimido(4,5-d)azepin-4-il)-amina kot modulatorji trpv 1 za zdravljenje boleäśine
IL204640A0 (en) Pharmaceutical compositions containing benfotiamine and one or one more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin
EP2045253A4 (en) alpha-amino acid derivative and pharmaceutical agent containing it as an active ingredient
EP1905452A4 (en) AGENT FOR THE PREVENTION OR TREATMENT OF GLAUCOMA
CY2018006I2 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
EP2137175A4 (en) NOVEL PHENANTHRENNEQUINONE-BASED COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR THE TREATMENT OR PREVENTION OF METABOLIC SYNDROME INVOLVING DISEASES
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
TWI369988B (en) New pharmaceutically active compounds for the treatment of respiratory diseases
BRPI0716374A2 (pt) "dispositivos médicos"
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
ATE532787T1 (de) Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus
EP2801359A3 (en) The use of nicotine for the treatment of sepsis in humans caused by antibiotic
EE200800065A (et) Prasoloprimidinoonhendit sisaldav toimeaine eesn„„rmesuurenemuse „rahoidmiseks ja raviks